Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErpolat, O. P.
dc.contributor.authorAlco, G.
dc.contributor.authorCaglar, H. B.
dc.contributor.authorIgdem, S.
dc.contributor.authorSaran, A.
dc.contributor.authorDagoglu, N.
dc.contributor.authorMandel, N. M.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T16:02:47Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T16:02:47Z
dc.date.issued2014
dc.identifier.issn0392-2936
dc.identifier.urihttp://hdl.handle.net/11446/2914
dc.descriptionWOS: 000341554300015en_US
dc.descriptionPubMed ID: 24654465en_US
dc.description.abstractPurpose: To compare the incidence and severity of acute and chronic hematologic toxicity (HT) in patients treated with three-dimensional conformal radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) for curative treatment of cervical cancer and to ascertain the dosimetric parameters of two techniques associated with acute and chronic HT. Materials and Methods: A total of 127 patients with cervical cancer receiving concomitant pelvic radiotherapy (RT) and cisplatin were evaluated. Pelvic bone marrow (BM) was contoured for each patient and divided into five sub-regions: lumbosacrum (LS), ilium (IL), lower pelvis (LP), pelvis (P), and whole pelvis (WP). The volume of each BM region receiving 10,20,30, and 40 Gy was calculated (V10, -V20, -V30, and -V40). The lowest level of hemoglobin, leukocyte, neutrophil, and platelet counts were obtained during chemoradiotherapy and six months after RT. The nadir values were graded according to Common Terminology Criteria for Adverse Events (version 3.0). Results: Grade 2 or greater acute anemia, leukopenia, neutropenia, thrombocytopenia was observed in 2%, 41.5%, 12%,and 0% in 3DCRT group and in 27%, 53%, 24.5%, and 4.5% in IMRT group, respectively. Grade 2 or greater chronic anemia, leukopenia, neutropenia, and thrombocytopenia was observed in 11%, 10%, 6%, and 0% in 3DCRT group and in 11%, 9%, 4.5%, and 0% in IMRT group, respectively. LS-V30,40; IL-V10,20,30,40; LP-V10,20,40; P-V10,20,30,40, and TP-V10,20,30,40 were significantly reduced with IMRT planning compared to 3DCRT planning. Logistic regression analysis of potential predictors showed that none of the dosimetric parameters were significant for predicting acute and chronic HT. Conclusion: The present findings showed that IMRT planning reduced irradiated BM volumes compared to 3DCRT planning. However, no difference between the two techniques was observed in terms of acute and chronic HT. Further studies are needed to confirm these results.en_US
dc.language.isoengen_US
dc.publisherI R O G CANADA, INCen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHematologic toxicityen_US
dc.subjectCervical canceren_US
dc.subjectRadiotherapyen_US
dc.subjectChemotherapyen_US
dc.titleComparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center studyen_US
dc.typearticleen_US
dc.relation.journalEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGYen_US
dc.departmentDBÜen_US
dc.identifier.issue1en_US
dc.identifier.volume35en_US
dc.identifier.startpage62en_US
dc.identifier.endpage66en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Erpolat, O. P. -- Akmansu, M. -- Kilic, D.] Gazi Univ, Sch Med, Dept Radiat Oncol, Ankara, Turkey -- [Alco, G.] Florence Nightingale Hosp, Dept Radiat Oncol, Istanbul, Turkey -- [Caglar, H. B.] Acibadem Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey -- [Igdem, S.] Bilim Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey -- [Saran, A.] Acibadem Hosp, Dept Radiat Oncol, Istanbul, Turkey -- [Dagoglu, N. -- Aslay, I.] Istanbul Univ, Inst Oncol, Dept Radiat Oncol, Istanbul, Turkey -- [Ozsaran, Z. -- Demirci, S.] Ege Univ, Sch Med, Dept Radiat Oncol, Izmir, Turkey -- [Keven, E. -- Guney, Y.] Dr Abdurrahman Yurtaslan Oncol Training & Res Hos, Ankara Dept Radiat Oncol, Ankara, Turkey -- [Bayman, E. -- Etiz, D.] Osmangazi Univ, Sch Med, Dept Radiat Oncol, Eskisehir, Turkey -- [Mandel, N. M.] Amer Hosp, Dept Med Oncol, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster